885958-67-8 Usage
General Description
Methyl-1-benzyl-4-methyl-pyrrolidine-3-carboxylate is a chemical compound commonly used in the pharmaceutical industry as a precursor in the synthesis of various drugs and medications. Its structured formula consists of a pyrrolidine ring with a methyl and benzyl group attached, as well as a carboxylate functional group. METHYL-1-BENZYL-4-METHYL-PYRROLIDINE-3-CARBOXYLATE is known for its potential as a central nervous system stimulant and has been studied for its potential use in the treatment of various neurological disorders. Additionally, it may also have applications in the creation of novel psychoactive substances. However,
Check Digit Verification of cas no
The CAS Registry Mumber 885958-67-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,9,5 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 885958-67:
(8*8)+(7*8)+(6*5)+(5*9)+(4*5)+(3*8)+(2*6)+(1*7)=258
258 % 10 = 8
So 885958-67-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO2/c1-11-8-15(10-13(11)14(16)17-2)9-12-6-4-3-5-7-12/h3-7,11,13H,8-10H2,1-2H3
885958-67-8Relevant articles and documents
INDAZOLYL-SPIRO[2.2]PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
-
Page/Page column 38, (2019/05/02)
The present invention is directed to substituted certain reversed indazolyl-spiro[2.2]pentane-carbonitrile derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, X, Y, and Z are as defined herein, which are potent inhibitors of LRRK2 kinase and may be useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
